| |
| |
|
| Insider
Information: |
Wang Xiaodong |
| Relationship: |
Chair, Scientific Advi... |
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,459,438 |
|
|
Indirect Shares
|
5,186,590 |
|
|
| Direct
Value |
$798,388,213 |
|
|
|
Indirect Value
|
$758,486,922 |
|
|
| Total
Shares |
10,646,028 |
|
|
| Total
Value |
$1,556,875,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -49.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
Chair, Scientific Advi... |
2023-11-30 |
5,459,438 |
2023-11-30 |
5,186,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGNE |
Beigene Ltd |
Director |
– • – |
2016-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,344,143 |
|
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2016-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
214,531 |
|
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
50 |
50 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-13 |
4 |
AS |
$0.00 |
$0 |
I/I |
(50) |
4,903,998 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-15 |
4 |
AS |
$202.05 |
$79,810 |
I/I |
(395) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-09 |
4 |
AS |
$250.00 |
$225,000 |
D/D |
(900) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2019-03-01 |
4 |
AS |
$150.00 |
$150,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-01 |
4 |
AS |
$170.00 |
$170,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-04 |
4 |
AS |
$190.00 |
$190,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-15 |
4 |
AS |
$202.05 |
$302,267 |
D/D |
(1,496) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-08-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,560 |
7,201,009 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-10 |
4 |
AS |
$250.09 |
$400,152 |
D/D |
(1,600) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-11-15 |
4 |
AS |
$210.14 |
$417,541 |
I/I |
(1,987) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-11 |
4 |
AS |
$250.39 |
$631,647 |
D/D |
(2,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-11-14 |
4 |
AS |
$193.57 |
$504,242 |
I/I |
(2,605) |
395 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-12-13 |
4 |
AS |
$210.59 |
$636,723 |
I/I |
(3,013) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2021-05-10 |
4 |
S |
$299.40 |
$1,019,752 |
D/D |
(3,394) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2021-05-10 |
4 |
OE |
$0.13 |
$441 |
D/D |
3,394 |
3,394 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2018-08-13 |
4 |
S |
$157.29 |
$547,591 |
D/D |
(3,449) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2019-03-01 |
4 |
AS |
$138.53 |
$584,125 |
I/I |
(4,000) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-08-10 |
4 |
AS |
$208.91 |
$844,229 |
I/I |
(4,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2017-02-27 |
4 |
S |
$38.10 |
$169,328 |
D/D |
(4,444) |
161,649 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2017-05-04 |
4 |
AS |
$41.01 |
$184,171 |
D/D |
(4,491) |
60,539 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2021-11-08 |
4 |
AS |
$343.10 |
$1,575,202 |
D/D |
(4,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2019-07-01 |
4 |
AS |
$126.13 |
$612,937 |
D/D |
(4,847) |
0 |
0 |
- |
|
79 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
